company background image
AMRS.Q logo

Amyris OTCPK:AMRS.Q Stock Report

Last Price

US$0.0002

Market Cap

US$186.2k

7D

-33.3%

1Y

-100.0%

Updated

28 Feb, 2024

Data

Company Financials

AMRS.Q Stock Overview

Amyris, Inc. operates as a biotechnology company in Europe, North America, Asia, South America, and internationally.

AMRS.Q fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

Amyris, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Amyris
Historical stock prices
Current Share PriceUS$0.0002
52 Week HighUS$1.50
52 Week LowUS$0.000001
Beta2
1 Month Change-88.24%
3 Month Change-98.40%
1 Year Change-99.98%
3 Year Change-100.00%
5 Year Change-100.00%
Change since IPO-100.00%

Recent News & Updates

Recent updates

What Does Amyris, Inc.'s (NASDAQ:AMRS) Share Price Indicate?

Apr 12
What Does Amyris, Inc.'s (NASDAQ:AMRS) Share Price Indicate?

Does This Valuation Of Amyris, Inc. (NASDAQ:AMRS) Imply Investors Are Overpaying?

Mar 22
Does This Valuation Of Amyris, Inc. (NASDAQ:AMRS) Imply Investors Are Overpaying?

At US$2.95, Is Amyris, Inc. (NASDAQ:AMRS) Worth Looking At Closely?

Oct 31
At US$2.95, Is Amyris, Inc. (NASDAQ:AMRS) Worth Looking At Closely?

Amyris Cost Breakdown

Oct 07

Recurring Marketing Exclusivity Deals Accelerate Amyris On Path To Profitability

Oct 01

Are Investors Undervaluing Amyris, Inc. (NASDAQ:AMRS) By 43%?

Sep 02
Are Investors Undervaluing Amyris, Inc. (NASDAQ:AMRS) By 43%?

Amyris: In Dire Need For Additional Capital

Aug 22

Amyris, Inc. (NASDAQ:AMRS) Just Reported, And Analysts Assigned A US$10.91 Price Target

Aug 12
Amyris, Inc. (NASDAQ:AMRS) Just Reported, And Analysts Assigned A US$10.91 Price Target

Amyris' Vertically-Integrated Business Model Transitioning From Investment Mode To Payoff Mode

Aug 08

Amyris: Revenues Need To Catch Expenses

Jul 08

Amyris: Elevated Cash Usage Causes Investors To Head For The Exits

May 11

Amryis Update: Building Value One Brick At A Time

Apr 28

Amyris: JVN Could Be Their Most Valuable Brand Yet

Mar 19

Shareholder Returns

AMRS.QUS ChemicalsUS Market
7D-33.3%1.7%2.1%
1Y-100.0%4.8%26.0%

Return vs Industry: AMRS.Q underperformed the US Chemicals industry which returned 4.9% over the past year.

Return vs Market: AMRS.Q underperformed the US Market which returned 25.1% over the past year.

Price Volatility

Is AMRS.Q's price volatile compared to industry and market?
AMRS.Q volatility
AMRS.Q Average Weekly Movement8,972.9%
Chemicals Industry Average Movement5.2%
Market Average Movement6.1%
10% most volatile stocks in US Market16.8%
10% least volatile stocks in US Market3.1%

Stable Share Price: AMRS.Q's share price has been volatile over the past 3 months.

Volatility Over Time: AMRS.Q's weekly volatility has increased from 4460% to 8973% over the past year.

About the Company

FoundedEmployeesCEOWebsite
20031,598Han Kieftenbeldhttps://amyris.com

Amyris, Inc. operates as a biotechnology company in Europe, North America, Asia, South America, and internationally. It creates, manufactures, and commercializes consumer products and ingredient, including clean beauty, personal care, and health and wellness consumer products; and ingredients to the flavor and fragrance, nutrition, food and beverage, and clean beauty and personal care end markets. The company markets its products under the Biossance, JVN, Rose Inc., Pipette, Costa Brazil, OLIKA, Purecane, Terasana, MenoLabs, EcoFabulous, Stripes, and 4U by Tia brand names.

Amyris, Inc. Fundamentals Summary

How do Amyris's earnings and revenue compare to its market cap?
AMRS.Q fundamental statistics
Market capUS$186.16k
Earnings (TTM)-US$614.55m
Revenue (TTM)US$268.22m

0.0x

P/S Ratio

0.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
AMRS.Q income statement (TTM)
RevenueUS$268.22m
Cost of RevenueUS$369.78m
Gross Profit-US$101.55m
Other ExpensesUS$512.99m
Earnings-US$614.55m

Last Reported Earnings

Mar 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-1.65
Gross Margin-37.86%
Net Profit Margin-229.12%
Debt/Equity Ratio-145.2%

How did AMRS.Q perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.